Johnson & Johnson News

Neurocrine Biosciences Upgraded at Wells Fargo on Pipeline

Seeking AlphaApr 24 11:59 ET

Johnson & Johnson Analyst Ratings

BenzingaApr 18 11:34 ET

HSBC Upgrades Johnson & Johnson to Buy, Raises Price Target to $170

BenzingaApr 18 11:41 ET

Johnson & Johnson Analyst Ratings

BenzingaApr 17 13:10 ET

Johnson & Johnson Analyst Ratings

BenzingaApr 17 06:32 ET

Johnson & Johnson Analyst Ratings

BenzingaApr 15 10:28 ET

Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)

TipRanksApr 15 07:45 ET

Morgan Stanley Trims Price Target on Johnson & Johnson to $168 From $169, Keeps Equalweight Rating

MT NewswiresApr 9 07:59 ET

Johnson & Johnson Analyst Ratings

BenzingaMar 13 12:14 ET

Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight

MT NewswiresFeb 28 10:50 ET

Johnson & Johnson Analyst Ratings

BenzingaFeb 28 10:20 ET

Johnson & Johnson Analyst Ratings

BenzingaFeb 20 12:34 ET

Johnson & Johnson Analyst Ratings

BenzingaFeb 6 09:51 ET

Johnson & Johnson (JNJ) Gets a Buy From Cantor Fitzgerald

TipRanksFeb 6 07:46 ET

Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $170, Maintains Equalweight Rating

MT NewswiresJan 24 11:27 ET

RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $181 Price Target

BenzingaJan 24 11:21 ET

Johnson & Johnson Analyst Ratings

BenzingaJan 24 11:20 ET

Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

TipRanksJan 23 23:15 ET

Johnson & Johnson Analyst Ratings

BenzingaJan 23 11:40 ET

Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target

BenzingaJan 9 08:59 ET